European Companies Search Engine

Word figurative mark: “DRIES BETTER“ Euipotm 20 Nov 2019 European Union Intellectual Property Office (Trade Marks)

History

Text

Trade mark

Type Figurative
Name DRIES BETTER
Graphic representation
Filing number 018091888
Trade mark status REGISTERED
Nice Classification

5: Pharmaceutical preparations.

9: Downloadable software in the nature of a mobile application for providing information relating to the treatment of ophthalmic diseases and disorders.

35: Business administration of patient reimbursement programs; business administration of medication reimbursement programs and services; business administration of pharmacy reimbursement programs and services.

41: Educational and training services, namely conducting classes, seminars, workshops, etc. in the field of ophthalmic diseases and disorders; providing online non-downloadable publications in the nature of articles, books and journals in the field of ophthalmic diseases and disorders and the monitoring and management of said diseases and disorders.

42: Providing temporary use of a non-downloadable web application for processing patient information related to ophthalmology.

44: Providing medical information in the field of ophthalmic diseases and disorders; medical services, namely assisting in the observation, monitoring, adherence and compliance of patients to medical treatments; doctor's appointment reminder services pertaining to patient visits to doctors, medical centers and specialists such as ophthalmologists.

45: Organizing and conducting support groups in the field of ophthalmology; Social networking services in the field of ophthalmological diseases and disorders and the monitoring and management of said diseases and disorders provided via a website.

Filing date 05/07/2019
Registration date 19/11/2019
Expiry date 05/07/2029
Owners

Novartis AG

c/o Novartis Pharma AG

Trademark Department

CH-4002 Basel

Switzerland

The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Novartis AG, Basle, Switzerland.